FERRING PHARMS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRING PHARMS INC, and what generic alternatives to FERRING PHARMS INC drugs are available?
FERRING PHARMS INC has nine approved drugs.
There are thirteen US patents protecting FERRING PHARMS INC drugs.
There are one hundred and eighty-four patent family members on FERRING PHARMS INC drugs in thirty-nine countries and fifteen supplementary protection certificates in nine countries.
Summary for FERRING PHARMS INC
International Patents: | 184 |
US Patents: | 13 |
Tradenames: | 9 |
Ingredients: | 4 |
NDAs: | 9 |
Drugs and US Patents for FERRING PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring Pharms Inc | DDAVP | desmopressin acetate | TABLET;ORAL | 019955-001 | Sep 6, 1995 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring Pharms Inc | DDAVP | desmopressin acetate | SOLUTION;NASAL | 017922-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | DISCN | Yes | No | 10,137,167 | ⤷ Sign Up | ⤷ Sign Up | ||||
Ferring Pharms Inc | PREPOPIK | citric acid; magnesium oxide; sodium picosulfate | FOR SOLUTION;ORAL | 202535-001 | Jul 16, 2012 | DISCN | Yes | No | 8,481,083 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | DISCN | Yes | No | 7,560,429 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Ferring Pharms Inc | MILPROSA | progesterone | SYSTEM;VAGINAL | 201110-001 | Apr 29, 2020 | DISCN | Yes | No | 10,537,584 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Ferring Pharms Inc | DDAVP | desmopressin acetate | INJECTABLE;INJECTION | 018938-001 | Mar 30, 1984 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FERRING PHARMS INC
Paragraph IV (Patent) Challenges for FERRING PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and 12 g | ➤ Subscribe | 2014-05-21 |
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and12 g | ➤ Subscribe | 2019-02-11 |
International Patents for FERRING PHARMS INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 1501534 | ⤷ Sign Up |
Slovenia | 2207526 | ⤷ Sign Up |
Japan | 5507467 | ⤷ Sign Up |
Taiwan | I315202 | ⤷ Sign Up |
Slovenia | 2359807 | ⤷ Sign Up |
Argentina | 107948 | ⤷ Sign Up |
Brazil | PI0818541 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for FERRING PHARMS INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3225249 | CA 2019 00023 | Denmark | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
2712622 | PA2017001 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DESMOPRESINAS ARBA JO ACETATO DRUSKA; REGISTRATION NO/DATE: BE497271, 2016-05-04; LT1-16/3940/001-LT/1 6/3940/008 |
2712622 | 122017000006 | Germany | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504 |
2782584 | 301153 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
2782584 | 2021C/558 | Belgium | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17--ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
2712622 | C02712622/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018 |
0113964 | 97C0037 | Belgium | ⤷ Sign Up | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.